Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable
Definitive Healthcare reports Q1 adjusted EPS of $0.08, sales at $63.48M, and adjusted EBITDA of $20 million. Q2 revenue guidance: $62–$63.5 million. FY 2024 revenue outlook: $255–$261 million.